Приказ основних података о документу
Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects
dc.creator | Vladimirov, Sandra | |
dc.creator | Gojković, Tamara | |
dc.creator | Spasojević-Kalimanovska, Vesna | |
dc.creator | Zeljković, Aleksandra | |
dc.creator | Vekić, Jelena | |
dc.creator | Kalimanovska-Oštrić, Dimitra | |
dc.creator | Jelić-Ivanović, Zorana | |
dc.date.accessioned | 2019-09-02T11:58:10Z | |
dc.date.available | 2019-09-02T11:58:10Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 0021-9150 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/2828 | |
dc.publisher | Elsevier Ireland Ltd, Clare | |
dc.rights | restrictedAccess | |
dc.source | Atherosclerosis | |
dc.title | Influence of LCAT and CETP activity on the reverse cholesterol transport and modification of HDL particles in statin-treated coronary artery disease patients and healthy subjects | en |
dc.type | conferenceObject | |
dc.rights.license | ARR | |
dcterms.abstract | Зељковић, Aлександра; Јелић-Ивановић, Зорана; Владимиров, Сандра; Векић, Јелена; Калимановска-Оштрић, Димитра; Гојковић, Тамара; Спасојевић-Калимановска, Весна; | |
dc.citation.volume | 263 | |
dc.citation.spage | e217 | |
dc.citation.epage | e217 | |
dc.citation.other | 263: - | |
dc.citation.rank | M21 | |
dc.description.other | 85th Congress of the European-Atherosclerosis-Society (EAS), 2017. | |
dc.identifier.wos | 000407634000671 | |
dc.identifier.doi | 10.1016/j.atherosclerosis.2017.06.708 | |
dc.identifier.pmid | 29365842 | |
dc.type.version | publishedVersion |